Altered TEG Parameters Identify Hypercoagulablilty and are of Diagnosis Value for Papillary Thyroid Carcinoma Patients

被引:9
|
作者
Lu, Songsong [1 ]
Kang, Rui [1 ]
Wang, Yongchao [1 ,2 ]
Zhu, Mengjie [1 ]
Zhao, Lei [1 ]
Xu, Qinzhu [1 ]
Song, Ying [1 ]
Liu, Chen [1 ]
机构
[1] Peking Univ, Dept Clin Lab, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] China Japan Friendship Hosp, Dept Clin Lab, Beijing, Peoples R China
关键词
thromboelastography; papillary thyroid carcinoma; nodular goiter; diagnosis; THROMBOELASTOGRAPHY; COAGULATION; CANCER; COAGULOPATHY; MANAGEMENT; SYSTEM; WOMEN;
D O I
10.1055/a-0723-3295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The goal of this study was to clarify the changes and clinical significance of thromboelastography(TEG) parameters in papillary thyroid carcinomas and nodular goiters. Methods 62 nodular goiter (NG) patients and 53 papillary thyroid carcinoma (PTC) patients were included. Coagulation indicators, together with a series of TEG parameters were collected and analyzed, compared with results of 61 healthy controls (HC). Correlation analysis was conducted between routine coagulation indicators and TEG parameters. ROC curves were used to evaluate the potential diagnosis value of the TEG parameters that were altered in papillary thyroid carcinoma patients. Results APTT and PT in papillary thyroid carcinoma group were statistically significant higher than that in control group (p <0.05). MPV was found to be higher in PTC than NG and healthy controls. R, K and SP levels were significantly lower in PTC group than that in HC group; Angle, CI and TPI levels were significantly higher in PTC group than that in HC group. Areas under the ROC curve of CI, TPI, and angle were 0.725, 0.714, and 0.687 for distinguishing PTC from HC, 0.662, 0.668 and 0.591 for distinguishing PTC from NG. Conclusion TEG parameters are altered and indicate hypercoagulablilty status of papillary thyroid carcinoma patients; CI, TPI, and angle could be potential diagnosis indicators for detecting papillary thyroid carcinoma.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 50 条
  • [41] Role of differentially expressed genes and long non-coding RNAs in papillary thyroid carcinoma diagnosis, progression, and prognosis
    Cai, Wei-Yang
    Chen, Xiong
    Chen, Li-Ping
    Li, Qian
    Du, Xiao-Jing
    Zhou, Yang-Yang
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (10) : 8249 - 8259
  • [42] Preoperative Prediction of Cervical Nodal Metastasis in Papillary Thyroid Carcinoma: Value of Quantitative Dual-Energy CT Parameters and Qualitative Morphologic Features
    Wu, Yao-yuan
    Wei, Chao
    Wang, Chuan-bin
    Li, Nai-yu
    Zhang, Ping
    Dong, Jiang-ning
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 216 (05) : 1335 - 1343
  • [43] Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
    Xie, Zhenyu
    Lun, Yu
    Li, Xin
    He, Yuzhen
    Wu, Song
    Wang, Shiyue
    Sun, Jianjian
    He, Yuchen
    Zhang, Jian
    AGING-US, 2020, 12 (18): : 18163 - 18180
  • [44] The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma
    Song, Linlin
    Zhu, Jingqiang
    Li, Zhihui
    Wei, Tao
    Gong, Rixiang
    Lei, Jianyong
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8451 - 8462
  • [45] Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years
    Ito, Yasuhiro
    Kihara, Minoru
    Takamura, Yuuki
    Kobayashi, Kaoru
    Miya, Akihiro
    Hirokawa, Mitsuyoshi
    Miyauchi, Akira
    ENDOCRINE JOURNAL, 2012, 59 (07) : 539 - 545
  • [46] A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients
    Wang, Zhiyan
    Lv, Jinru
    Zou, Xuan
    Huang, Zebo
    Zhang, Huo
    Liu, Qingxie
    Jiang, Lin
    Zhou, Xin
    Zhu, Wei
    GENE, 2019, 693 : 37 - 45
  • [47] The combined use of miRNAs and mRNAs as biomarkers for the diagnosis of papillary thyroid carcinoma
    Zhao, Yinlong
    Liu, Xiaodong
    Zhong, Lili
    He, Mengzi
    Chen, Silin
    Wang, Tiejun
    Ma, Shumei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (04) : 1097 - 1103
  • [48] Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis
    Liang, Huasheng
    Zhong, Yuhua
    Luo, Zuojie
    Huang, Yu
    Lin, Huade
    Luo, Min
    Zhan, Song
    Xie, Kaiqing
    Ma, Yan
    Li, Qingdi Quentin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2010, 25 (01) : 38 - 45
  • [49] Significant dysregulation of lipid metabolism in patients with papillary thyroid carcinoma after thyroidectomy
    Zhou, Liang
    Li, Shuo
    Wu, Yuqi
    Chen, Qianming
    Hu, Xiaotong
    Jiang, Junchang
    Shi, Yaoyao
    Shen, Dan
    Xie, Lei
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [50] The incidence and features of Delphian lymph node involvement in patients with papillary thyroid carcinoma
    Alibakhshi, Abbas
    Sheikhi, Saman
    Yazd, Seyed Mostafa Meshkati
    Ardekani, Ali
    Ranjbar, Keivan
    Shahriarirad, Reza
    BMC SURGERY, 2022, 22 (01)